Arylmethoxypyridines as novel, potent and orally active mGlu5 receptor antagonists
摘要:
Optimisation of affinity, chemical stability, metabolic stability and solubility led from a chemically labile HTS hit 1 to mGlu5 receptor antagonists (24-26) with high affinity for the allosteric M PEP binding site, improved microsomal metabolic stability and anxiolytic-like activity in vivo as assessed by the Vogel conflict drinking test. (C) 2006 Elsevier Ltd. All rights reserved.
Arylmethoxypyridines as novel, potent and orally active mGlu5 receptor antagonists
摘要:
Optimisation of affinity, chemical stability, metabolic stability and solubility led from a chemically labile HTS hit 1 to mGlu5 receptor antagonists (24-26) with high affinity for the allosteric M PEP binding site, improved microsomal metabolic stability and anxiolytic-like activity in vivo as assessed by the Vogel conflict drinking test. (C) 2006 Elsevier Ltd. All rights reserved.